policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
UNDER REVIEWEnvironmental responsibility is a One Health issue
The AVMA supports environmental responsibility, including these specific measures.
policy
Foot and mouth disease
Foot-and-mouth disease (FMD) is a severe, highly contagious viral disease of worldwide concern. View AVMA's recommendations for FMD preparedness and…
policy
Joint AVMA-FVE-CVMA statement on the role of veterinarians in advancing One Health—A global public good
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.